Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

14.59
-0.2300-1.55%
Post-market: 14.58-0.0100-0.07%19:59 EDT
Volume:4.86M
Turnover:72.03M
Market Cap:4.73B
PE:-26.74
High:15.02
Open:14.78
Low:14.56
Close:14.82
52wk High:15.02
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:0.83
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:5.28
PE(LYR):-29.77

Loading ...

AbCellera Biologics (ABCL) Gets a Buy from BMO Capital

TIPRANKS
·
Aug 18

Abcellera Director Michael R Hayden Reports Purchase of Common Shares Worth $481,234.19

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

AbCellera Dips After $200 Mln Share Sale for Menopause Drug

Reuters
·
Aug 13

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares

Reuters
·
Aug 13

AbCellera Prices Oversubscribed Public Offering at USD 9.75 Per Share to Raise USD 200 Million

Reuters
·
Aug 13

Abcellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 13

Abcellera Biologics Inc.: Pricing of Public Offering of 17,435,897 Shares at a Price of $9.75 Per Share

THOMSON REUTERS
·
Aug 13

Shares of Abcellera Biologics Down 7.9% Premarket After Launching $200 Mln Stock Offering

THOMSON REUTERS
·
Aug 12

AbCellera Biologics (ABCL) On ABCL635 Trial Results And A Richer Valuation Story

Simply Wall St.
·
Aug 12

AbCellera Biologics Launches $200 Million Public Offering

MT Newswires Live
·
Aug 12

Canada's Eupraxia Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 12

AbCellera Slips After Launching $200 Mln Stock Offering to Fund Menopause Drug

Reuters
·
Aug 12

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Aug 12

AbCellera Umumkan Penawaran Saham Lanjutan Senilai USD 200 Juta

Reuters
·
Aug 12

Abcellera Biologics - Proceeds to Fund Pipeline Research, Clinical Advancement, and Working Capital

THOMSON REUTERS
·
Aug 12

Abcellera Biologics - Announces $200 Mln Public Offering of Common Shares and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 12

AbCellera Biologics is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 12

Abcellera Biologics Inc. : Truist Securities Raises Target Price to $30 from $12

THOMSON REUTERS
·
Aug 11

Canada's Medexus Q1 Revenue Beats on Grafapex Strength

Reuters
·
Aug 11